(Q61591076)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

DNA haplotype dependency of debrisoquine 4-hydroxylase (CYP2D6) expression among extensive metabolisers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Evelyne Jacqz-Aigrain

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

C Mura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M Vincent-Viry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M M Galteau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

R Krishnamoorthy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 October 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

367-372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01247337

28 October 2019

exact match

0 references

cites work

Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study

1 reference

12 December 2020

NcoI RFLP in the pseudogene (CYP2D8P) of the human debrisoquine 4-hydroxylase locus

1 reference

12 December 2020

Chromosomal assignment of human cytochrome P-450 (debrisoquine/sparteine type) to chromosome 22.

1 reference

12 December 2020

Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes

1 reference

12 December 2020

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

1 reference

12 December 2020

Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype

1 reference

12 December 2020

P450 genes: structure, evolution, and regulation

1 reference

12 December 2020

Direct determination of dextromethorphan and its three metabolites in urine by high-performance liquid chromatography using a precolumn switching system for sample clean-up

1 reference

12 December 2020

Molecular heterogeneity of the XbaI defined 44kb allele of the CYP2D locus within the Caucasian population

1 reference

12 December 2020

Metabolic oxidation phenotypes as markers for susceptibility to lung cancer

1 reference

12 December 2020

The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature

1 reference

12 December 2020

Molecular genotyping to predict debrisoquine hydroxylation phenotype

1 reference

12 December 2020

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

1 reference

12 December 2020

Molecular genetics of the debrisoquin-sparteine polymorphism

1 reference

12 December 2020

Phenotyping polymorphic drug metabolism in the French Caucasian population

1 reference

12 December 2020

The human CYP2D locus associated with a common genetic defect in drug oxidation: a G1934----A base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3' splice recognition site

1 reference

12 December 2020

Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype

1 reference

12 December 2020

The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects

1 reference

12 December 2020

Debrisoquine oxidation phenotype and susceptibility to lung cancer

1 reference

12 December 2020

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1 reference

12 December 2020

Identification of the primary gene defect at the cytochrome P450 CYP2D locus.

1 reference

12 December 2020

Phenotypic differences in dextromethorphan metabolism

1 reference

12 December 2020

Detection of debrisoquine hydroxylation phenotypes

1 reference

12 December 2020

Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics

1 reference

12 December 2020

Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs

1 reference

12 December 2020

The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene

1 reference

12 December 2020

Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes

1 reference

12 December 2020

The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms

1 reference

12 December 2020

Genetically determined oxidation capacity and the disposition of debrisoquine

1 reference

12 December 2020

Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism

1 reference

12 December 2020

Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population

1 reference

12 December 2020

Clinical significance of the sparteine/debrisoquine oxidation polymorphism

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01247337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7901140%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 October 2019

0 references

1 reference